ReviewFrontiers in immunology2026
Unilateral facial palsy with hemiplegia and positive anti-GT1a antibody: a case report and literature review.
Review in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Guillain-Barré syndrome (GBS) is an autoimmune-mediated disorder characterized by an acute onset of symmetrical flaccid limb weakness. However, cases of persistent unilateral limb weakness and facial palsy with anti-GT1a antibody positivity have been rarely reported. Here, we describe this case to highlight its clinical importance. Case: A 60-year-old man presented with right shoulder and upper back pain, followed by right-sided limb weakness, peripheral facial paralysis, distal sensory impairment, and dyspnea. Symptoms were preceded by upper respiratory infection. Cerebrospinal fluid showed albuminocytological dissociation. Electromyography reported peripheral nerve damage in the extremities. Serum anti-GT1a IgG was positive. After a five-day course of intravenous immunoglobulin, he showed marked recovery in motor, sensory, and respiratory function. At six-month follow-up, his symptoms except dyspnea basically returned to normal. Conclusion: This case suggests a potential distinct GBS phenotype featuring unilateral limb weakness, unilateral facial palsy, and anti-GT1a antibody positivity, with a good response to IVIG. These findings expand the clinical spectrum of GBS and emphasize recognizing unilateral presentations to prevent misdiagnosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.